· What is surrounding AI in drug discovery?
· What can we do with data to enhance efficiency?
· How are we validating processes and running tests and reviewing data?
· What infrastructure challenges have been faced so far and how are we trying to overcome these hurdles
· What are the next steps for Enginzyme?